Invenire Partners, LP - Q3 2022 holdings

$65.3 Million is the total value of Invenire Partners, LP's 26 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 76.9% .

 Value Shares↓ Weighting
HROW SellHarrow Health Inc$5,477,293,000
+46.4%
453,794
-11.7%
8.38%
+68.6%
SellArena Group Holdings Inc$3,161,750,000
-9.2%
241,355
-37.6%
4.84%
+4.6%
CLAR SellClarus Corp$2,116,002,000
-37.1%
157,090
-11.3%
3.24%
-27.5%
ASPN ExitAspen Aerogels Inc$0-24,494
-100.0%
-0.32%
NDLS ExitNoodles & Co$0-191,953
-100.0%
-1.20%
CYRX ExitCryoport Inc$0-45,283
-100.0%
-1.86%
MX ExitMagnaChip Semiconductor Corp$0-115,000
-100.0%
-2.22%
SHYF ExitShyft Group Inc$0-103,100
-100.0%
-2.54%
CMCO ExitColumbus McKinnon Corp$0-68,597
-100.0%
-2.58%
ExitEdgio Inc$0-865,000
-100.0%
-2.65%
DLA ExitDelta Apparel Inc$0-96,358
-100.0%
-3.63%
UIS ExitUnisys Corp$0-268,000
-100.0%
-4.28%
NOA ExitNorth American Construction Group Ltd$0-308,270
-100.0%
-4.49%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DHI Group Inc4Q3 20227.9%
Tetra Technologies Inc4Q3 20226.5%
Harrow Health Inc4Q3 20228.4%
TTEC Holdings Inc4Q3 20225.9%
Clarus Corp4Q3 20225.9%
Apyx Medical Corp4Q3 20226.5%
InfuSystem Holdings Inc4Q3 20225.1%
PAR Technology Corp4Q3 20224.9%
Cantaloupe Inc4Q3 20225.2%
Marcus Corp4Q3 20224.4%

View Invenire Partners, LP's complete holdings history.

Latest filings
TypeFiled
SC 13G/A2023-03-31
SC 13G2023-01-23
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-13
13F-HR2022-02-14
D/A2019-03-12
D2018-01-02

View Invenire Partners, LP's complete filings history.

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (65274000.0 != 65398496000.0)

Export Invenire Partners, LP's holdings